Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors

AIDS. 2006 Apr 24;20(7):1087-9. doi: 10.1097/01.aids.0000222092.97776.cd.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • Atazanavir Sulfate
  • Drug Interactions
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Oligopeptides / therapeutic use*
  • Prospective Studies
  • Pyridines / therapeutic use*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Ritonavir / therapeutic use*

Substances

  • Anti-Retroviral Agents
  • HIV Protease Inhibitors
  • Oligopeptides
  • Pyridines
  • Reverse Transcriptase Inhibitors
  • Atazanavir Sulfate
  • Ritonavir